2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.69% |
4.23% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.87% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.62% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.5% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.38% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.63% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.82% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.65% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
6.4% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
6.4% |
0% |
2024-10-18 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
6.4% |
0% |
2024-10-18 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
6.4% |
0% |
2024-10-18 |
CUTR
Cutera, Inc.
|
Sell |
-3.3% |
12% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.76% |
-0.31% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.75% |
0.35% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.96% |
-0.33% |
2024-10-17 |
The percentage of cash held in the portfolio is:
34%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AXSM |
Buy
All
|
-7.81% |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.66% |
5.63% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.14% |
5.52% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.53% |
-3.15% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.44% |
10.41% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.35% |
8.99% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.61% |
-1.95% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.72% |
-0.34% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
7% |
3.83% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.89% |
2.27% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-3.34% |
9.25% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.68% |
0% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.64% |
1.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.84% |
-3.9% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.87% |
0% |
2024-10-17 |
The percentage of cash held in the portfolio is:
56.03%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORMP |
Buy
All
|
-1.67% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.57% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.1% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.73% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.83% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.99% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.79% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.82% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.81% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.81% |
0% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-3.42% |
8% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.53% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.66% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.58% |
4.11% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.73% |
0.18% |
2024-10-07 |
The percentage of cash held in the portfolio is:
56.47%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.45% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.9% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.79% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.85% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
CUTR
Cutera, Inc.
|
Sell |
-3.54% |
5.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.55% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.72% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.47% |
7.61% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.7% |
1.35% |
2024-10-07 |
The percentage of cash held in the portfolio is:
70.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.43% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.88% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.87% |
0% |
2024-10-14 |
CUTR
Cutera, Inc.
|
Sell |
-3.8% |
-1.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.61% |
3.74% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.74% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.43% |
8.99% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.81% |
-1.12% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.21%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.34% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.75% |
-1.95% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.64% |
2.67% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.43% |
8.41% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.76% |
-0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.44% |
8.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.61% |
4.05% |
2024-10-07 |
The percentage of cash held in the portfolio is:
104.79%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.48% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.89% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.89% |
0% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.76% |
-0.31% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.68% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.76% |
0% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.76% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.45%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.43% |
0% |
2024-10-03 |
CUTR
Cutera, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
104.82%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CERS |
Buy
All
|
16.11% |
NVCR |
Sell
All
|
-11.63% |
Assets Rebalanced
None
2024-09-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
7.18% |
-8.98% |
2024-09-06 |
CERS
Cerus Corporation
|
Sell |
-3.46% |
14.69% |
2024-09-05 |
The percentage of cash held in the portfolio is:
96.28%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
-1.56% |
Assets Rebalanced
None
2024-09-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
7.57% |
-3.32% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.61% |
2.48% |
2024-09-09 |
CERS
Cerus Corporation
|
Sell |
-3.43% |
14.69% |
2024-09-05 |
The percentage of cash held in the portfolio is:
88.25%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-8.2% |
Assets Rebalanced
None
2024-09-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.54% |
-4.92% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.59% |
-2.44% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.79% |
5.56% |
2024-09-09 |
CERS
Cerus Corporation
|
Sell |
-3.38% |
15.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
79.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LMAT |
Buy
All
|
0.21% |
AVXL |
Buy
All
|
6.46% |
PODD |
Sell
All
|
15.5% |
Assets Rebalanced
None
2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.83% |
15.22% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.73% |
-2.73% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.77% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.82% |
6.04% |
2024-09-09 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.72% |
0.25% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.47% |
7.14% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.73% |
6.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
76.77%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
0.59% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.82% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.69% |
-3.83% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.79% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.68% |
3.45% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.7% |
3.06% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
-1.08% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.64% |
3.06% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.93% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
81.07%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-2.28% |
AADI |
Sell
All
|
7.43% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.31% |
1.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.82% |
12.73% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.43% |
2.85% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.77% |
-4.37% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.26% |
31.25% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.63% |
-3.99% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.37% |
-2.15% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.58% |
7.41% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.77% |
0.97% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.38% |
11.39% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.95% |
3.32% |
2024-09-05 |
The percentage of cash held in the portfolio is:
56.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
8.41% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
6.13% |
3.11% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.59% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.75% |
11.4% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.5% |
3.13% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.76% |
-4.92% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.04% |
27.5% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.62% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.38% |
-2.56% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.64% |
6.36% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.73% |
2.57% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.34% |
12.76% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.99% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
49.92%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
2.22% |
APLS |
Sell
All
|
-3.75% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.84% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
5.93% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.37% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.69% |
10.8% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.34% |
1.42% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.7% |
-5.46% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.47% |
33.75% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.47% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.58% |
0.26% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.62% |
6.89% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.71% |
3.03% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.26% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.98% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.98% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.16%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
0.85% |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.93% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.35% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.55% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.45% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.33% |
7.2% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.01% |
-1.71% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.51% |
-7.1% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.45% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.3% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.58% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.28% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.59% |
7.17% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.7% |
2.83% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.34% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.57% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.91% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
46.93%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
-0.8% |
PACB |
Buy
All
|
-22.96% |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
6.22% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.67% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.47% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.66% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.34% |
5.05% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.67% |
-7.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.44% |
-9.84% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.24% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.89% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
7.58% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.69% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.3% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.8% |
3.86% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.85% |
1.1% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.41% |
12.41% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.55% |
-17.04% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.28% |
0.24% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.11% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.99% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.43%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.91% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.6% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.62% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.48% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.51% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.34% |
5.72% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.95% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.74% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.4% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.08% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.05% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.34% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.78% |
3.61% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.82% |
1.07% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.65% |
5.44% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.01% |
-3.7% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.26% |
0.1% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.24% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.08% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
50.51%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.68% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.71% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.62% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.31% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.49% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.17% |
3.96% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.78% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.23% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.48% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.07% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.42% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.81% |
2.72% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.83% |
0.61% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.69% |
4.42% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.77% |
2.22% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.63% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
58.46%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.85% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.79% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.43% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.29% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
8.94% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.92% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.7% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.31% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.16% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.62% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.92% |
0.15% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
1.75% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.59% |
7.14% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.84% |
0.74% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.84% |
2024-09-02 |
The percentage of cash held in the portfolio is:
44.96%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-2.98% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.68% |
-2.4% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.92% |
1.77% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.11% |
4.96% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.48% |
-5.85% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.34% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.92% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.5% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.47% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.8% |
0.38% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.89% |
-2.22% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.92% |
-2.93% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
-1.4% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.84% |
-2.38% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.79% |
-1.23% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.8% |
-1.48% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.17% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
47.08%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.58% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.04% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.44% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.78% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.89% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.75% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.57% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.57% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.68% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.75% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.82% |
-0.3% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.75% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
- LMAT
- AVXL
- VERU
- PACB
- PODD
- EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.98% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.02% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.92% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.91% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.82% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.82% |
0% |
2024-08-28 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.66% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.76% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.76% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
63.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.09% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.14% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.11% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6% |
0% |
2024-08-27 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.65% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.71% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.93% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.81% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.07% |
6.03% |
2024-08-23 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.75% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
74.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.51% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.63% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
71.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
82.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Buy
All
|
24.66% |
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.69% |
25.56% |
2024-07-31 |
The percentage of cash held in the portfolio is:
102.69%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
4.43% |
CYH |
Sell
All
|
-1.57% |
Assets Rebalanced
None
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7% |
-2.95% |
2024-07-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.72% |
24.66% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.16% |
12.45% |
2024-07-31 |
The percentage of cash held in the portfolio is:
98.88%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CPRX |
Buy
All
|
-6.15% |
PODD |
Buy
All
|
-2.48% |
NKTR |
Buy
All
|
10.37% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.63% |
-7.66% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-3.6% |
2.34% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.22% |
12.59% |
2024-07-19 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.51% |
30.04% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.22% |
10.34% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.75% |
5.86% |
2024-08-01 |
The percentage of cash held in the portfolio is:
109.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
INGN |
Buy
All
|
-20.7% |
RMD |
Sell
All
|
1.39% |
RCM |
Sell
All
|
7.14% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
6.08% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
6.68% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.05% |
3.67% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.54% |
2.25% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.13% |
13.33% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.14% |
10.89% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.41% |
31.84% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.25% |
8.02% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.52% |
10.15% |
2024-08-01 |
The percentage of cash held in the portfolio is:
92.18%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BKD |
Sell
All
|
-5.42% |
FATE |
Sell
All
|
7.71% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.03% |
-1.06% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.85% |
19.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.1% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
6.88% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.5% |
7.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.63% |
-0.76% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.2% |
11.11% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.27% |
6.97% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.68% |
23.77% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.41% |
2.95% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.73% |
4.47% |
2024-08-01 |
The percentage of cash held in the portfolio is:
83.55%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Buy
All
|
-17.98% |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.23% |
1.06% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.25% |
25.45% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.3% |
8.44% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.1% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.94% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.36% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.41% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.94% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.3% |
3.13% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.74% |
-1.17% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.82% |
-3.2% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.48% |
5.93% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.58% |
0.87% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.27% |
9.42% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.64% |
-0.84% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.94% |
1.8% |
2024-08-01 |
The percentage of cash held in the portfolio is:
60.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGRY |
Sell
All
|
18.28% |
RGNX |
Sell
All
|
4.72% |
AVNS |
Sell
All
|
12.13% |
CUTR |
Sell
All
|
-12.16% |
ANGO |
Sell
All
|
27.08% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGRY
Surgery Partners, Inc.
|
Buy |
7.03% |
18.83% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.63% |
12.12% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.68% |
12.94% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.6% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.5% |
27.9% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.25% |
2.25% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.69% |
37.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.7% |
-1.15% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.4% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.94% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.66% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.13% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.1% |
2.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.66% |
0.31% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.87% |
-5.24% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.65% |
0.74% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.61% |
-0.76% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.62% |
-0.9% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.64% |
-1.69% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.98% |
0% |
2024-08-01 |
The percentage of cash held in the portfolio is:
26.69%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Buy
All
|
-6.87% |
OPK |
Sell
All
|
7.58% |
PDSB |
Sell
All
|
1.14% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.78% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.24% |
-1.7% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.44% |
22.27% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.84% |
12.43% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.59% |
8.4% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.92% |
-2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.72% |
27.73% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.42% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.63% |
31.88% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.87% |
-1% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.46% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.13% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
8.67% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.23% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.11% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.14% |
0% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.75% |
0.6% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.94% |
-4.51% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.89% |
-2.96% |
2024-07-19 |
SMTI
Sanara MedTech Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
INGN
Inogen, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
16.14%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.68% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.69% |
8.52% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.28% |
21.76% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.75% |
12.9% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.46% |
8.03% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.65% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.39% |
24.96% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.38% |
4.37% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.84% |
39.07% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.67% |
-2.61% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.29% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
6.84% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
7.36% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.11% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
8.74% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.11% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.07% |
0% |
2024-07-30 |
PODD
Insulet Corporation
|
Sell |
-3.65% |
1.61% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.92% |
-5.75% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.74% |
-0.74% |
2024-07-19 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Buy
All
|
-5.84% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.82% |
12.12% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.71% |
10.23% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.4% |
25.32% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.66% |
12.75% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.46% |
9.25% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.07% |
2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.28% |
24.8% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.39% |
5.69% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.8% |
39.85% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.75% |
-0.19% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.24% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.65% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-3.64% |
0.85% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.85% |
-4.86% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
-2.22% |
2024-07-19 |
RMD
ResMed Inc.
|
Sell |
-3.75% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- RMD
- SMTI
- CYH
- HQY
- SAVA
- SAGE
Assets Removed
Asset |
Action |
Perf % |
WAT |
Buy
All
|
-5.03% |
ATRC |
Sell
All
|
-12.65% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.62% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.84% |
11.93% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.16% |
20.35% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.73% |
13.22% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.44% |
8.22% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.63% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.18% |
22.51% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.32% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.8% |
38.82% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.11% |
-7% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.75% |
-0.84% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.53% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.58% |
0% |
2024-07-26 |
PODD
Insulet Corporation
|
Sell |
-3.61% |
2.09% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.89% |
-5.33% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
-1.48% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.74% |
-2.5% |
2024-07-22 |
The percentage of cash held in the portfolio is:
32.32%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.68% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.64% |
6.96% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.98% |
16.16% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.45% |
7.32% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.41% |
6.7% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.85% |
-2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.07% |
19.58% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.38% |
3.7% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.62% |
33.16% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.3% |
-5.18% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.91% |
0.92% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.66% |
0% |
2024-07-25 |
PODD
Insulet Corporation
|
Sell |
-3.72% |
0.3% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.93% |
-5.45% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.9% |
-4.44% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.72% |
-0.86% |
2024-07-22 |
The percentage of cash held in the portfolio is:
40.32%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.87% |
10.61% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.88% |
10.8% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.67% |
10.29% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.08% |
0.47% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.43% |
6.28% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.66% |
10.14% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.9% |
16.31% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.37% |
2.78% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.98% |
17.22% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.29% |
-5.85% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
6.02% |
2.15% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.74% |
0.37% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.9% |
-3.93% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-4.06% |
-8.15% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.77% |
-1.49% |
2024-07-22 |
The percentage of cash held in the portfolio is:
48.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
13.4% |
RYTM |
Sell
All
|
16.66% |
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.01% |
9.54% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.12% |
16.17% |
2024-07-02 |
OPK
OPKO Health, Inc.
|
Buy |
6.01% |
12.88% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.85% |
9.94% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.89% |
13.7% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6% |
-1.02% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.29% |
3.82% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.51% |
7.43% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.98% |
17.13% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.31% |
1.19% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.67% |
9.77% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.4% |
-4.47% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
6.03% |
2% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.76% |
-0.04% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.74% |
0.54% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.87% |
-2.96% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.72% |
0% |
2024-07-22 |
The percentage of cash held in the portfolio is:
36.04%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
TDOC |
Sell
All
|
-2.99% |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.99% |
9.54% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.06% |
15.44% |
2024-07-02 |
ALT
Altimmune, Inc.
|
Buy |
5.1% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
6.11% |
15.15% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.81% |
9.66% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.88% |
13.89% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.11% |
1.1% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6% |
-0.64% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.4% |
5.95% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.33% |
4.73% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.69% |
13.38% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.31% |
1.59% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.7% |
10.8% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.51% |
-2.49% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.8% |
-1.46% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.75% |
0% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.75% |
0% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
0% |
2024-07-19 |
The percentage of cash held in the portfolio is:
21.44%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Buy
All
|
-0.97% |
CYH |
Sell
All
|
17.81% |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.15% |
23.12% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.08% |
15.37% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.18% |
22.05% |
2024-07-02 |
ALT
Altimmune, Inc.
|
Buy |
5.62% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.5% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.82% |
13.92% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.73% |
15.66% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.08% |
4.48% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.23% |
7.04% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.22% |
6.89% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.57% |
12.84% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.89% |
20.72% |
2024-07-12 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.71% |
-1.88% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.18% |
2.25% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.69% |
14.65% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.37% |
-0.91% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.67% |
0% |
2024-07-18 |
FGEN
FibroGen, Inc.
|
Sell |
-3.69% |
-3.88% |
2024-06-28 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None
2024-07-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.17% |
25% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.29% |
20.89% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.32% |
26.29% |
2024-07-02 |
BHVN
Biohaven Ltd.
|
Buy |
5.84% |
4.86% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.01% |
8.29% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.51% |
9.09% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.94% |
17.76% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.27% |
8.92% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.14% |
6.69% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.2% |
7.68% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6% |
4.2% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.45% |
12.16% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.92% |
22.51% |
2024-07-12 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.68% |
-1.26% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.08% |
0.93% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.73% |
16.97% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.36% |
0% |
2024-07-17 |
FGEN
FibroGen, Inc.
|
Sell |
-3.89% |
-10.68% |
2024-06-28 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
13.6% |
Assets Rebalanced
None
2024-07-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.71% |
11.57% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.36% |
21.88% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.11% |
11.2% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.43% |
21.63% |
2024-07-02 |
BHVN
Biohaven Ltd.
|
Buy |
6.25% |
6.27% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.19% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.78% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
6.4% |
20.03% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.12% |
0.74% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.15% |
1.26% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.01% |
-1.17% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.01% |
-1.18% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.32% |
4.05% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.6% |
-3.26% |
2024-07-12 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.84% |
-3.96% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.27% |
0% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.27% |
0% |
2024-07-16 |
FGEN
FibroGen, Inc.
|
Sell |
-3.82% |
-2.91% |
2024-06-28 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
APLS |
Buy
All
|
-10.22% |
ACAD |
Sell
All
|
13.54% |
EGRX |
Sell
All
|
33.26% |
Assets Rebalanced
None
2024-07-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
6.46% |
11.9% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.24% |
34.37% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.86% |
13.27% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.24% |
18.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.83% |
5.15% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.24% |
17.23% |
2024-07-02 |
BHVN
Biohaven Ltd.
|
Buy |
6.24% |
5.28% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.24% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.62% |
4.55% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
6.24% |
16.19% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.44% |
5.17% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.16% |
0.47% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.14% |
0.21% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.1% |
-0.47% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.09% |
-0.68% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.74% |
-2.12% |
2024-07-12 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.94% |
-3.1% |
2024-07-12 |
FGEN
FibroGen, Inc.
|
Sell |
-3.78% |
-0.97% |
2024-06-28 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.37% |
-8.93% |
2024-07-02 |
The percentage of cash held in the portfolio is:
2.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGMO |
Buy
All
|
-25% |
CDNA |
Buy
All
|
-10.41% |
Assets Rebalanced
Asset |
Action |
Weight |
VRDN |
Sell |
-0.97% |
OPK |
Sell |
-1.34% |
BHVN |
Sell |
-0.77% |
ALT |
Sell |
-0.79% |
RYTM |
Sell |
-1.33% |
PDSB |
Sell |
-1.49% |
EGRX |
Sell |
-1.51% |
CYH |
Sell |
-1.55% |
ANGO |
Buy |
0.25% |
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
6.52% |
11.15% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.89% |
34.6% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.78% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.73% |
15.94% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.44% |
-1.97% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.17% |
9.21% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.46% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
7.1% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.95% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.02% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.23% |
0% |
2024-07-12 |
FGEN
FibroGen, Inc.
|
Sell |
-3.61% |
4.95% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-4.83% |
-22.22% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.37% |
-7.16% |
2024-07-02 |
CDNA
CareDx, Inc
|
Sell |
-3.83% |
-9.44% |
2024-07-11 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- WST
- ANGO
- TDOC
- SGRY
- AVNS
- CUTR
- RGNX
Assets Removed
Asset |
Action |
Perf % |
PAHC |
Buy
All
|
-6.77% |
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
6.44% |
7.75% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.06% |
34.82% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.69% |
6.55% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.09% |
4.37% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.21% |
-7.12% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.96% |
4.01% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
6.9% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
6.9% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.9% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
6.9% |
0% |
2024-07-11 |
FGEN
FibroGen, Inc.
|
Sell |
-3.39% |
12.33% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-4.47% |
-11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.29% |
-3.17% |
2024-07-02 |
PAHC
Phibro Animal Health Corporation
|
Sell |
-3.57% |
0% |
2024-07-11 |
CDNA
CareDx, Inc
|
Sell |
-3.57% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
50.27%
New Assets Added
- PAHC
- CDNA
- PDSB
- BHVN
- ALT
- OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
6.39% |
7.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.03% |
35.49% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.59% |
6.02% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.99% |
3.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.2% |
-6.59% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.99% |
5.32% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-3.13% |
18.54% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.88% |
2.78% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.26% |
-3.44% |
2024-07-02 |
The percentage of cash held in the portfolio is:
70.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Sell
All
|
-11.61% |
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
6.07% |
2.77% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.93% |
34.15% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.46% |
4.12% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.8% |
1.25% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.43% |
-2.79% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.17% |
-6.81% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.79% |
2.55% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-3.01% |
21.46% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.54% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.19% |
-1.98% |
2024-07-02 |
The percentage of cash held in the portfolio is:
64.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
-3.41% |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.82% |
-1.83% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.28% |
22.77% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.28% |
0.9% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.09% |
5.31% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.46% |
-2.67% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.15% |
-7.27% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.35% |
-4.36% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
6.86% |
3.41% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.58% |
32.91% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.55% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.02% |
2.42% |
2024-07-02 |
The percentage of cash held in the portfolio is:
57.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
1.87% |
Assets Rebalanced
None
2024-07-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.88% |
-0.25% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.88% |
16.74% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.51% |
5.2% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.36% |
2.79% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.18% |
7.19% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.4% |
-3.02% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.08% |
-7.95% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.55% |
-0.77% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
7.13% |
7.95% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.76% |
27.86% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.53% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-3.96% |
3.61% |
2024-07-02 |
The percentage of cash held in the portfolio is:
51.25%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CHRS |
Sell
All
|
-19.65% |
MNKD |
Sell
All
|
-7.37% |
ARDX |
Sell
All
|
-28.74% |
Assets Rebalanced
None
2024-07-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.74% |
1.01% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.33% |
-6.26% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.02% |
23.44% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.69% |
12.05% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.16% |
3.19% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.7% |
3.75% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
6.95% |
2.16% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
6.33% |
-6.94% |
2024-07-01 |
NVRO
Nevro Corp.
|
Buy |
6.37% |
0% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.75% |
25.24% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.51% |
8.33% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-3.96% |
0% |
2024-07-02 |
The percentage of cash held in the portfolio is:
33.83%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Buy
All
|
-8.17% |
MODV |
Buy
All
|
-8.11% |
Assets Rebalanced
None
2024-07-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.81% |
2.33% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.46% |
-3.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.09% |
25% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.7% |
12.5% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.15% |
3.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.77% |
5% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
6.79% |
0% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
6.79% |
0% |
2024-07-01 |
NVRO
Nevro Corp.
|
Sell |
-3.89% |
-5.78% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.82% |
-4.83% |
2024-06-27 |
FGEN
FibroGen, Inc.
|
Sell |
-3.18% |
13.4% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.82% |
0% |
2024-07-01 |
The percentage of cash held in the portfolio is:
63.15%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.93% |
3.09% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.6% |
-2.58% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.44% |
12.05% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.67% |
10.52% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.28% |
3.94% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.54% |
0% |
2024-06-28 |
NVRO
Nevro Corp.
|
Sell |
-3.92% |
-5.03% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.73% |
-0.84% |
2024-06-27 |
FGEN
FibroGen, Inc.
|
Sell |
-3.73% |
0% |
2024-06-28 |
The percentage of cash held in the portfolio is:
73.9%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Buy
All
|
-12.3% |
Assets Rebalanced
None
2024-06-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.64% |
-2.39% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.52% |
-4.42% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.35% |
9.82% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.52% |
7.54% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.17% |
1.71% |
2024-06-26 |
NVRO
Nevro Corp.
|
Sell |
-4.01% |
-7.16% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.71% |
0% |
2024-06-27 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.71% |
0% |
2024-06-27 |
The percentage of cash held in the portfolio is:
81.24%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Sell
All
|
-12.08% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.68% |
-1.76% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.58% |
-3.5% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
5.64% |
-2.5% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.88% |
1.56% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.07% |
0% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.07% |
0% |
2024-06-26 |
NVRO
Nevro Corp.
|
Sell |
-3.75% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
68.82%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.76% |
0% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
76.94%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-06 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SLP |
Buy
All
|
5.86% |
RCM |
Sell
All
|
2% |
Assets Rebalanced
None
2024-06-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
-1.31% |
2.32% |
2024-05-16 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.18% |
7.98% |
2024-05-23 |
The percentage of cash held in the portfolio is:
104.49%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ICUI |
Buy
All
|
-6.33% |
Assets Rebalanced
None
2024-05-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
-1.33% |
3.92% |
2024-05-16 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.35% |
0.44% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.37% |
2.5% |
2024-05-23 |
The percentage of cash held in the portfolio is:
109.05%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Buy
All
|
14.16% |
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
-1.32% |
3.04% |
2024-05-16 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.77% |
13.87% |
2024-05-10 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.25% |
2.74% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.35% |
2.88% |
2024-05-23 |
The percentage of cash held in the portfolio is:
111.69%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Buy
All
|
-12.87% |
BKD |
Buy
All
|
6.57% |
Assets Rebalanced
None
2024-05-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
-1.31% |
2% |
2024-05-16 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.64% |
4.29% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.83% |
12.37% |
2024-05-10 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.42% |
-0.88% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.89% |
-11.55% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.44% |
0.46% |
2024-05-23 |
The percentage of cash held in the portfolio is:
120.54%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MDRX |
Buy
All
|
-16.51% |
VKTX |
Buy
All
|
5.36% |
ILMN |
Buy
All
|
6.9% |
Assets Rebalanced
None
2024-05-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
-1.27% |
-0.16% |
2024-05-16 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.7% |
-0.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.47% |
5.62% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.62% |
3.57% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.78% |
12.94% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.78% |
9.14% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.23% |
2.22% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.4% |
-1.65% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.4% |
0.3% |
2024-05-23 |
The percentage of cash held in the portfolio is:
130.65%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AORT |
Sell
All
|
13.62% |
OMCL |
Sell
All
|
8.3% |
NUTX |
Sell
All
|
9.74% |
Assets Rebalanced
None
2024-05-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AORT
Artivion, Inc.
|
Buy |
7.86% |
13% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.4% |
5.21% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.98% |
8.86% |
2024-05-06 |
RCM
R1 RCM Inc.
|
Buy |
-1.24% |
-2.92% |
2024-05-16 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.82% |
-3.46% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.47% |
6.18% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.6% |
4.57% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.8% |
12.58% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.73% |
10.85% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.36% |
-0.29% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.55% |
-4.62% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.41% |
0.62% |
2024-05-23 |
The percentage of cash held in the portfolio is:
108.74%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALT |
Sell
All
|
2.78% |
GKOS |
Sell
All
|
2.29% |
KIDS |
Sell
All
|
-0.25% |
VCYT |
Sell
All
|
-7.38% |
Assets Rebalanced
None
2024-05-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALT
Altimmune, Inc.
|
Buy |
8.3% |
9.74% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.69% |
2.57% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.96% |
4.21% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.84% |
13.52% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.48% |
7% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.84% |
7.38% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
6.03% |
-3.91% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.23% |
-2.72% |
2024-05-16 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.71% |
-1.2% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.49% |
4.81% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.63% |
3.14% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.91% |
8.7% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.79% |
8.76% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.38% |
-1.55% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.67% |
-8.25% |
2024-05-20 |
SLP
Simulations Plus, Inc.
|
Sell |
-3.41% |
0% |
2024-05-23 |
The percentage of cash held in the portfolio is:
79.09%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Buy
All
|
-8.78% |
PODD |
Sell
All
|
-2.32% |
INGN |
Sell
All
|
22.55% |
SGMO |
Sell
All
|
18.52% |
ACRS |
Sell
All
|
-8.73% |
Assets Rebalanced
None
2024-05-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
8.1% |
22.13% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.59% |
11.11% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.25% |
-6.35% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.15% |
7.09% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.8% |
3.33% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.97% |
3.62% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.79% |
12.09% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.45% |
5.91% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.88% |
7.24% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
6.12% |
-3.2% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.25% |
-1.76% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
5.6% |
-1.4% |
2024-05-17 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.79% |
-2.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.52% |
4.62% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.72% |
1.57% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-2.97% |
7.4% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.89% |
6.99% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.29% |
1.2% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.74% |
-9.08% |
2024-05-20 |
ANGO
AngioDynamics, Inc.
|
Sell |
-3.18% |
-0.86% |
2024-05-21 |
The percentage of cash held in the portfolio is:
48.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SENS |
Sell
All
|
-3.49% |
Assets Rebalanced
None
2024-05-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.26% |
-3.7% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.2% |
24.26% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.7% |
12.96% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.27% |
-5.56% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.47% |
11.82% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.81% |
4.04% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.82% |
2.26% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.87% |
13.76% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.13% |
1.99% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.77% |
6.21% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
6.23% |
-0.89% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.24% |
-2.08% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
5.61% |
-0.67% |
2024-05-17 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.79% |
-3.2% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.53% |
3.8% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.68% |
2% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.1% |
2.73% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-4.07% |
2.24% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.29% |
0.72% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.4% |
-1.82% |
2024-05-20 |
ANGO
AngioDynamics, Inc.
|
Sell |
-3.14% |
0% |
2024-05-21 |
The percentage of cash held in the portfolio is:
41.11%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ALGN |
Buy
All
|
12.26% |
CARA |
Sell
All
|
-0.79% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.04% |
-0.79% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.44% |
-0.41% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.19% |
25.25% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
10.25% |
20.37% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.21% |
-5.56% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.37% |
11.4% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.78% |
4.53% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.63% |
0.66% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.69% |
12.09% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.01% |
1.03% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.63% |
4.74% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
6.34% |
1.69% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.25% |
-0.56% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
5.66% |
1.02% |
2024-05-17 |
ALGN
Align Technology, Inc.
|
Sell |
-3.44% |
10.93% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.66% |
-0.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.59% |
1.55% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.68% |
1.29% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.06% |
3.31% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-4% |
2.98% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.29% |
0% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.29% |
0% |
2024-05-20 |
The percentage of cash held in the portfolio is:
33.01%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IBRX |
Sell
All
|
-14.91% |
PTCT |
Sell
All
|
15.84% |
RYTM |
Sell
All
|
-8.38% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.17% |
19.11% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.51% |
6.48% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.13% |
-13.79% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.44% |
1.03% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.19% |
26.95% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.48% |
12.96% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.05% |
-6.35% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.33% |
-5.45% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
9.16% |
23.78% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.72% |
5.12% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.47% |
-0.06% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.59% |
12.28% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.19% |
5.08% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.76% |
8.41% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
6.39% |
4% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.22% |
-1.52% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
5.52% |
0% |
2024-05-17 |
ALGN
Align Technology, Inc.
|
Sell |
-3.42% |
10.26% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.75% |
-4.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.64% |
-1.45% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.71% |
-1% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.28% |
-5.18% |
2024-05-10 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-4.07% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Buy
All
|
1.33% |
MD |
Sell
All
|
-8.68% |
Assets Rebalanced
None
2024-05-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.13% |
17.82% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.08% |
0.53% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.49% |
-9.9% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.55% |
1.85% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.13% |
25.39% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.06% |
7.41% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.09% |
-6.35% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.45% |
-4.42% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
9.19% |
23.37% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.83% |
6.06% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.41% |
-1.38% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.71% |
13.38% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
6.82% |
-0.86% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.62% |
5.62% |
2024-05-06 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
5.94% |
-3.87% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
6.47% |
4.67% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
-1.25% |
0% |
2024-05-16 |
NVRO
Nevro Corp.
|
Sell |
-3.94% |
6.71% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.52% |
8.04% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.61% |
0.13% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.68% |
-1.94% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.76% |
-1.71% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.21% |
-2.59% |
2024-05-10 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FOLD |
Buy
All
|
-6.86% |
ITGR |
Buy
All
|
-7.43% |
WST |
Sell
All
|
-4.6% |
Assets Rebalanced
None
2024-05-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.85% |
10.96% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.17% |
-0.79% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
8.18% |
-4% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.93% |
-8.83% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.31% |
25.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.81% |
1.85% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.26% |
-6.35% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.76% |
-2.97% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.82% |
2.5% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.81% |
3.17% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.54% |
-2.14% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.34% |
-2.79% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.72% |
10.85% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.21% |
2.22% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.61% |
2.82% |
2024-05-06 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
6.33% |
0% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
6.33% |
0% |
2024-05-14 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.45% |
-2.84% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.9% |
9.98% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.51% |
10.52% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.81% |
-2.8% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.7% |
0.04% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.78% |
0.14% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.31% |
-3.09% |
2024-05-10 |
FOLD
Amicus Therapeutics, Inc.
|
Sell |
-3.53% |
0% |
2024-05-14 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MD |
Buy
All
|
-0.35% |
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.07% |
12.88% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.88% |
-5.29% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.78% |
-9.68% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.35% |
-4.31% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.06% |
20% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.07% |
3.7% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.28% |
-7.14% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.63% |
-5.53% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.75% |
0.42% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
8.04% |
5.17% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.61% |
-2.26% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.54% |
-1.16% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.92% |
12.42% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.12% |
-0.03% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.03% |
-7.18% |
2024-05-06 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.55% |
-4.01% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.79% |
13.52% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.54% |
10.87% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.88% |
-3.73% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.67% |
2.03% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.7% |
3.29% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.86% |
-0.86% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.24% |
0.07% |
2024-05-10 |
The percentage of cash held in the portfolio is:
15.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
IOVA |
Sell
All
|
-12.24% |
Assets Rebalanced
None
2024-05-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.6% |
8.68% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.18% |
0.53% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.55% |
-10.34% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.41% |
-1.23% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.1% |
23.26% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.07% |
7.6% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.23% |
-3.7% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.45% |
-2.78% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.34% |
-7.07% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.1% |
7.37% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.66% |
2.47% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
8.02% |
5.28% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.4% |
-0.78% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.7% |
11.8% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7% |
0.4% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.17% |
-2.91% |
2024-05-06 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.46% |
-4.24% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.98% |
7.16% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.57% |
8.01% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.78% |
-3.2% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.61% |
1.3% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.6% |
3.88% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.83% |
-2.43% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.17% |
0% |
2024-05-10 |
The percentage of cash held in the portfolio is:
8.99%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ACHC |
Buy
All
|
-6.61% |
CDMO |
Sell
All
|
7.67% |
Assets Rebalanced
None
2024-05-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.73% |
9% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
8.01% |
-3.04% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7% |
10.85% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.53% |
-11.9% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.44% |
-2.26% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
7.79% |
16.88% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.14% |
7.12% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.03% |
-7.41% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.53% |
-3.17% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.53% |
-6.06% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.62% |
-0.42% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.72% |
1.79% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
8.06% |
4.31% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.53% |
-0.49% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.78% |
11.32% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.03% |
-0.56% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.13% |
-4.82% |
2024-05-06 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.48% |
-3.25% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.9% |
10.25% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.54% |
10.23% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-3.09% |
0.09% |
2024-05-06 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.76% |
-1.33% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.64% |
1.95% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.79% |
0% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.79% |
0% |
2024-05-09 |
The percentage of cash held in the portfolio is:
2.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
Asset |
Action |
Weight |
CARA |
Buy |
0.4% |
SGMO |
Buy |
0.51% |
KIDS |
Buy |
0.58% |
WST |
Buy |
0.9% |
IBRX |
Buy |
1.05% |
ACRS |
Buy |
1.08% |
RYTM |
Buy |
1.27% |
2024-05-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.73% |
11.27% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.55% |
4.76% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.17% |
15.87% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.62% |
-8.12% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.68% |
2.87% |
2024-05-01 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.3% |
11.84% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.43% |
0% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.94% |
6.35% |
2024-05-02 |
INGN
Inogen, Inc.
|
Buy |
6.76% |
3.55% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.2% |
-5.02% |
2024-05-02 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.12% |
9.09% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.64% |
2.81% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
7.58% |
1.11% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.53% |
-0.03% |
2024-05-03 |
AORT
Artivion, Inc.
|
Buy |
7.77% |
13.57% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
6.96% |
0.56% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.66% |
-10.41% |
2024-05-06 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.39% |
-3.25% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.33% |
-1.86% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.63% |
6% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-3.09% |
-1.98% |
2024-05-06 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.64% |
0% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.64% |
0% |
2024-05-08 |
The percentage of cash held in the portfolio is:
2.07%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Buy
All
|
-6.93% |
Assets Rebalanced
Asset |
Action |
Weight |
PTCT |
Buy |
0.45% |
ALT |
Buy |
0.5% |
SENS |
Buy |
0.64% |
2024-05-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
6.93% |
15.37% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.57% |
4.5% |
2024-04-30 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.3% |
-13.13% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
6.93% |
11.38% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.54% |
3.49% |
2024-05-01 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.95% |
5.91% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.29% |
11.04% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.83% |
3.97% |
2024-05-02 |
INGN
Inogen, Inc.
|
Buy |
6.7% |
1.99% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.33% |
-1.85% |
2024-05-02 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.93% |
5.63% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
6.72% |
2.36% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.47% |
-0.02% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.53% |
-0.52% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
6.93% |
-0.5% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
6.93% |
0.67% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
6.29% |
-1% |
2024-05-06 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.43% |
-3.62% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.36% |
-1.96% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.21% |
1.5% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.66% |
5.72% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-3.13% |
-2.51% |
2024-05-06 |
The percentage of cash held in the portfolio is:
2.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ATRI |
Buy
All
|
-10.12% |
Assets Rebalanced
Asset |
Action |
Weight |
SENS |
Sell |
-0.96% |
NUTX |
Sell |
-1.66% |
OMCL |
Sell |
-1.06% |
PTCT |
Sell |
-1.13% |
CDMO |
Sell |
-1.14% |
AORT |
Sell |
-1.15% |
GKOS |
Buy |
0.37% |
SGMO |
Buy |
0.48% |
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.97% |
15.54% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.28% |
1.78% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.8% |
9.13% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.36% |
2.94% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.41% |
3.68% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
6.57% |
1.42% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.99% |
7.94% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.06% |
9.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.67% |
2.93% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.84% |
5.62% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
6.57% |
1.41% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.42% |
-0.93% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.69% |
3.21% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
6.58% |
1.53% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
7.92% |
0% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
7.92% |
0% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.92% |
0% |
2024-05-06 |
ATRI
Atrion Corporation
|
Sell |
-4.43% |
-5.05% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.21% |
0.27% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.29% |
-1.54% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.42% |
-4.7% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.62% |
5.56% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-3.01% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMMT |
Sell
All
|
13.73% |
Assets Rebalanced
None
2024-05-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.3% |
17.68% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
7.42% |
5.18% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.3% |
-0.22% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.93% |
8.47% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.47% |
2.12% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.78% |
6.37% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
6.61% |
-0.28% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.89% |
3.97% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
6.83% |
3.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.38% |
-3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.55% |
-1.09% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
6.62% |
0% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.62% |
0% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.62% |
0% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
6.62% |
0% |
2024-05-03 |
ATRI
Atrion Corporation
|
Sell |
-4.54% |
-5.05% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.25% |
1.5% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.33% |
-0.31% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.4% |
-1.92% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.68% |
6% |
2024-04-30 |
The percentage of cash held in the portfolio is:
15.25%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.47% |
19.57% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
8.62% |
21.76% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.97% |
-5.01% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.45% |
1.46% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.37% |
0.4% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.98% |
-4.93% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
6.65% |
0% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.65% |
0% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
6.65% |
0% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.65% |
0% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.65% |
0% |
2024-05-02 |
ATRI
Atrion Corporation
|
Sell |
-4.68% |
-8.07% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.99% |
8.04% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.34% |
-0.18% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.35% |
-0.31% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.67% |
6.66% |
2024-04-30 |
The percentage of cash held in the portfolio is:
41.91%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Buy
All
|
37.91% |
BKD |
Buy
All
|
-5.26% |
FATE |
Buy
All
|
34.77% |
Assets Rebalanced
None
2024-05-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.13% |
12.53% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
7.35% |
1.81% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.66% |
-11.12% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.56% |
0.93% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.45% |
-0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.49% |
0% |
2024-05-01 |
NUTX
Nutex Health Inc.
|
Sell |
-2.05% |
38.01% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.37% |
-1.95% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.08% |
37% |
2024-04-11 |
ATRI
Atrion Corporation
|
Sell |
-4.74% |
-7.16% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.13% |
6.54% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.5% |
-1.87% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.43% |
-0.08% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.71% |
7.36% |
2024-04-30 |
The percentage of cash held in the portfolio is:
84.39%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.14% |
12.5% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
7.28% |
0.52% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.51% |
0% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.51% |
0% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.51% |
0% |
2024-04-30 |
NUTX
Nutex Health Inc.
|
Sell |
-2.13% |
35.86% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.44% |
-3.75% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.14% |
35.57% |
2024-04-11 |
ATRI
Atrion Corporation
|
Sell |
-4.71% |
-6.33% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.47% |
-0.88% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.63% |
-4.55% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.47% |
-0.77% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-4.02% |
0% |
2024-04-30 |
The percentage of cash held in the portfolio is:
92.07%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.27% |
0% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
7.27% |
0% |
2024-04-29 |
NUTX
Nutex Health Inc.
|
Sell |
-2.26% |
32.17% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.48% |
-4.5% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.02% |
39.39% |
2024-04-11 |
ATRI
Atrion Corporation
|
Sell |
-4.45% |
0% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-4.45% |
0% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-4.45% |
0% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-4.45% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
111.02%
New Assets Added
- ATRI
- NVRO
- ITGR
- OFIX
- PTCT
- SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NUTX
Nutex Health Inc.
|
Sell |
-2.36% |
29.41% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.31% |
0.9% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.55% |
23.76% |
2024-04-11 |
The percentage of cash held in the portfolio is:
108.22%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
-6.11% |
Assets Rebalanced
None
2024-04-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.55% |
-6.11% |
2024-04-02 |
NUTX
Nutex Health Inc.
|
Sell |
-2.24% |
32.89% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.27% |
2.1% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.69% |
19.62% |
2024-04-11 |
The percentage of cash held in the portfolio is:
97.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
UTHR |
Buy
All
|
-3.14% |
Assets Rebalanced
None
2024-04-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.71% |
-4.58% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-6.8% |
-2.43% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-2.26% |
32.17% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.24% |
3% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.81% |
15.95% |
2024-04-11 |
The percentage of cash held in the portfolio is:
104.4%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
11.05% |
KIDS |
Sell
All
|
3.21% |
ACRS |
Sell
All
|
-2.38% |
Assets Rebalanced
None
2024-04-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
11.25% |
10.7% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
10.68% |
5.11% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.76% |
-3.97% |
2024-03-28 |
OPK
OPKO Health, Inc.
|
Buy |
10.52% |
-6.11% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-6.78% |
-2.33% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-1.82% |
45.39% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.16% |
5.11% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3% |
10.05% |
2024-04-11 |
The percentage of cash held in the portfolio is:
72.56%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-9.75% |
Assets Rebalanced
None
2024-04-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
11.32% |
11.75% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.62% |
-5.1% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
10.87% |
7.32% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.73% |
-3.97% |
2024-03-28 |
OPK
OPKO Health, Inc.
|
Buy |
10.49% |
-6.11% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-6.69% |
-1.25% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-2.29% |
31.25% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.23% |
2.85% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.06% |
7.97% |
2024-04-11 |
The percentage of cash held in the portfolio is:
63.23%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RVNC |
Sell
All
|
-16.06% |
Assets Rebalanced
None